These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1804637)

  • 1. Calcium channel blockers and ischaemic heart disease: theoretical expectations and clinical experience.
    Ferrari R; Visioli O
    Eur Heart J; 1991 Dec; 12 Suppl F():18-24. PubMed ID: 1804637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of calcium antagonists against ischaemia and reperfusion damage.
    Ferrari R; Visioli O
    Drugs; 1991; 42 Suppl 1():14-26; discussion 26-7. PubMed ID: 1718690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists.
    Nayler WG
    Drugs; 1991; 42 Suppl 2():21-7. PubMed ID: 1718698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channels in the heart.
    Poole-Wilson PA
    Postgrad Med J; 1991; 67 Suppl 3():S16-9. PubMed ID: 1661893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of calcium antagonists in ischaemic heart disease.
    Pepine CJ
    Eur Heart J; 1995 Aug; 16 Suppl H():19-24. PubMed ID: 8846801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA.
    Chouairi S; Carrie D; Puel J
    Eur Heart J; 1995 Aug; 16 Suppl H():3-8. PubMed ID: 8846802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in ischemic heart disease].
    Guize L
    J Mal Vasc; 1997 Oct; 22(4):222-8. PubMed ID: 9411006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists and coronary heart disease. An overview].
    Gasser R; Eber B; Schwarz T; Schafhalter E; Klein W
    Wien Med Wochenschr; 1993; 143(19-20):500-9. PubMed ID: 8135032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium antagonists on infarcting myocardium.
    Kloner RA; Braunwald E
    Am J Cardiol; 1987 Jan; 59(3):84B-94B. PubMed ID: 3544791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
    Reimer KA; Jennings RB
    Am J Cardiol; 1985 Jan; 55(3):107B-115B. PubMed ID: 3881903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists.
    Higgins AJ; Blackburn KJ
    J Mol Cell Cardiol; 1984 May; 16(5):427-38. PubMed ID: 6737483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists and coronary artery disease: an opportunity missed?
    Curtis MJ
    J Neural Transm Suppl; 1990; 31():17-38. PubMed ID: 2074436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary and tertiary prevention with calcium antagonists in coronary artery disease.
    Burkart F
    Drugs; 1992; 43 Suppl 1():37-42. PubMed ID: 1378787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
    Boden WE
    Drugs; 1996; 52 Suppl 4():20-30. PubMed ID: 8913715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH
    Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac effects of the extract and active components of radix stephaniae tetrandrae. II. Myocardial infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart.
    Yu XC; Wu S; Wang GY; Shan J; Wong TM; Chen CF; Pang KT
    Life Sci; 2001 May; 68(25):2863-72. PubMed ID: 11432452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.